Horwitz S - Search Results

1

Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis.

Stoll JR, Willner J, Oh Y, Pulitzer M, Moskowitz A, Horwitz S, Myskowski P, Noor SJ. Stoll JR, et al. Among authors: horwitz s. J Am Acad Dermatol. 2021 Nov;85(5):1073-1090. doi: 10.1016/j.jaad.2021.04.080. Epub 2021 Apr 30. J Am Acad Dermatol. 2021. PMID: 33940098 Review.

2

Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma.

Straus DJ, Duvic M, Kuzel T, Horwitz S, Demierre MF, Myskowski P, Steckel S. Straus DJ, et al. Among authors: horwitz s. Cancer. 2007 May 1;109(9):1799-803. doi: 10.1002/cncr.22596. Cancer. 2007. PMID: 17366595 Free article. Clinical Trial.

3

Rare T-cell lymphomas.

Molina AM, Horwitz SM. Molina AM, et al. Cancer Treat Res. 2008;142:331-47. doi: 10.1007/978-0-387-73744-7_14. Cancer Treat Res. 2008. PMID: 18283793 Review.

4

Review of the treatment of mycosis fungoides and sézary syndrome: a stage-based approach.

Horwitz SM, Olsen EA, Duvic M, Porcu P, Kim YH. Horwitz SM, et al. J Natl Compr Canc Netw. 2008 Apr;6(4):436-42. doi: 10.6004/jnccn.2008.0033. J Natl Compr Canc Netw. 2008. PMID: 18433609 Review.

5

Indolent primary cutaneous B-cell lymphoma: experience using systemic rituximab.

Morales AV, Advani R, Horwitz SM, Riaz N, Reddy S, Hoppe RT, Kim YH. Morales AV, et al. Among authors: horwitz sm. J Am Acad Dermatol. 2008 Dec;59(6):953-7. doi: 10.1016/j.jaad.2008.08.005. Epub 2008 Sep 24. J Am Acad Dermatol. 2008. PMID: 18817999

6

Novel therapies for cutaneous T-cell lymphomas.

Horwitz SM. Horwitz SM. Clin Lymphoma Myeloma. 2008 Dec;8 Suppl 5:S187-92. doi: 10.3816/CLM.2008.s.015. Clin Lymphoma Myeloma. 2008. PMID: 19073526 Review.

7

Characterization of T-cell lymphomas by FDG PET/CT.

Feeney J, Horwitz S, Gönen M, Schöder H. Feeney J, et al. Among authors: horwitz s. AJR Am J Roentgenol. 2010 Aug;195(2):333-40. doi: 10.2214/AJR.09.3665. AJR Am J Roentgenol. 2010. PMID: 20651187

8

The emerging role of histone deacetylase inhibitors in treating T-cell lymphomas.

Horwitz SM. Horwitz SM. Curr Hematol Malig Rep. 2011 Mar;6(1):67-72. doi: 10.1007/s11899-010-0067-5. Curr Hematol Malig Rep. 2011. PMID: 21080243 Review.

9

Clinical roundtable monograph. The management of aggressive T-cell lymphoma: a discussion on transformed mycosis fungoides.

Horwitz SM, Duvic M, Hsi ED. Horwitz SM, et al. Clin Adv Hematol Oncol. 2010 Dec;8(12):1-15. Clin Adv Hematol Oncol. 2010. PMID: 21344783

10

Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations.

Mehta N, Wayne AS, Kim YH, Hale GA, Alvarado CS, Myskowski P, Jaffe ES, Busam KJ, Pulitzer M, Zwerner J, Horwitz S. Mehta N, et al. Among authors: horwitz s. Clin Lymphoma Myeloma Leuk. 2012 Feb;12(1):20-5. doi: 10.1016/j.clml.2011.06.016. Epub 2011 Oct 15. Clin Lymphoma Myeloma Leuk. 2012. PMID: 22001256 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

952 results

Search Page

Filters